1. Home
  2. BETR vs KMDA Comparison

BETR vs KMDA Comparison

Compare BETR & KMDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Better Home & Finance Holding Company

BETR

Better Home & Finance Holding Company

HOLD

Current Price

$25.22

Market Cap

538.7M

Sector

Finance

ML Signal

HOLD

Logo Kamada Ltd.

KMDA

Kamada Ltd.

HOLD

Current Price

$7.18

Market Cap

460.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BETR
KMDA
Founded
2014
1990
Country
United States
Israel
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
538.7M
460.3M
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
BETR
KMDA
Price
$25.22
$7.18
Analyst Decision
Buy
Strong Buy
Analyst Count
1
2
Target Price
$40.00
$14.00
AVG Volume (30 Days)
365.3K
55.4K
Earning Date
05-07-2026
05-13-2026
Dividend Yield
N/A
3.08%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$55.02
$13.94
Revenue Next Year
$65.66
$9.84
P/E Ratio
N/A
$24.59
Revenue Growth
N/A
N/A
52 Week Low
$11.90
$6.50
52 Week High
$94.06
$9.35

Technical Indicators

Market Signals
Indicator
BETR
KMDA
Relative Strength Index (RSI) 37.92 31.34
Support Level $24.91 $6.57
Resistance Level $29.98 $7.41
Average True Range (ATR) 2.11 0.14
MACD 0.16 -0.05
Stochastic Oscillator 19.97 12.95

Price Performance

Historical Comparison
BETR
KMDA

About BETR Better Home & Finance Holding Company

Better Home & Finance Holding Co is a technology-enabled homeownership company that provides mortgage, home equity, and related services through a digital platform. The company operates through two reportable segments: Home Finance, which focuses on residential mortgage origination, including purchase, refinance, and home equity products, generating revenue mainly from loan sales; and Banking, which, through its U.K. subsidiary Birmingham Bank, offers a range of financial products and services to consumers and small businesses. It generates the majority of its revenue from the Home Finance segment.

About KMDA Kamada Ltd.

Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.

Share on Social Networks: